Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zika Virus Infection | 7 | 2021 | 36 | 2.400 |
Why?
|
| Zika Virus | 6 | 2021 | 35 | 1.250 |
Why?
|
| BK Virus | 4 | 2016 | 23 | 1.160 |
Why?
|
| Nicaragua | 11 | 2021 | 17 | 0.900 |
Why?
|
| Dengue | 6 | 2021 | 96 | 0.820 |
Why?
|
| Serologic Tests | 3 | 2022 | 37 | 0.790 |
Why?
|
| Antibodies, Viral | 7 | 2024 | 322 | 0.760 |
Why?
|
| Fomites | 2 | 2021 | 4 | 0.750 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 545 | 0.710 |
Why?
|
| Dengue Virus | 6 | 2021 | 99 | 0.700 |
Why?
|
| Tumor Virus Infections | 2 | 2016 | 36 | 0.620 |
Why?
|
| Chikungunya Fever | 1 | 2019 | 4 | 0.620 |
Why?
|
| Chikungunya virus | 1 | 2019 | 3 | 0.620 |
Why?
|
| Polyomavirus Infections | 2 | 2016 | 45 | 0.620 |
Why?
|
| Asymptomatic Infections | 1 | 2019 | 29 | 0.600 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2018 | 10 | 0.590 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 26 | 0.590 |
Why?
|
| Epidemiological Monitoring | 1 | 2018 | 31 | 0.580 |
Why?
|
| Virus Replication | 4 | 2021 | 319 | 0.550 |
Why?
|
| Seroepidemiologic Studies | 4 | 2023 | 52 | 0.540 |
Why?
|
| Salivary Glands | 2 | 2015 | 46 | 0.540 |
Why?
|
| Saliva | 3 | 2024 | 103 | 0.530 |
Why?
|
| Salivary Gland Diseases | 1 | 2016 | 2 | 0.510 |
Why?
|
| Pharynx | 1 | 2016 | 25 | 0.500 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 674 | 0.500 |
Why?
|
| Viral Load | 4 | 2020 | 231 | 0.490 |
Why?
|
| Child, Preschool | 9 | 2021 | 1967 | 0.470 |
Why?
|
| Child | 10 | 2021 | 4482 | 0.430 |
Why?
|
| Sensitivity and Specificity | 3 | 2023 | 1141 | 0.410 |
Why?
|
| Adolescent | 10 | 2023 | 6197 | 0.400 |
Why?
|
| Molecular Diagnostic Techniques | 3 | 2020 | 32 | 0.360 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2023 | 455 | 0.360 |
Why?
|
| Epidemics | 3 | 2021 | 24 | 0.340 |
Why?
|
| Humans | 27 | 2024 | 62924 | 0.330 |
Why?
|
| Vero Cells | 3 | 2021 | 80 | 0.320 |
Why?
|
| Female | 15 | 2024 | 32584 | 0.320 |
Why?
|
| Male | 14 | 2024 | 29590 | 0.300 |
Why?
|
| HIV Infections | 1 | 2016 | 965 | 0.300 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 2558 | 0.260 |
Why?
|
| Middle Aged | 8 | 2024 | 17403 | 0.250 |
Why?
|
| Cohort Studies | 4 | 2021 | 2553 | 0.240 |
Why?
|
| Adult | 7 | 2024 | 16669 | 0.240 |
Why?
|
| Spike Glycoprotein, Coronavirus | 2 | 2023 | 113 | 0.230 |
Why?
|
| DNA, Viral | 2 | 2016 | 232 | 0.220 |
Why?
|
| Aerosols | 2 | 2021 | 47 | 0.220 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 36 | 0.200 |
Why?
|
| RNA, Viral | 3 | 2022 | 276 | 0.200 |
Why?
|
| Virus Shedding | 2 | 2021 | 20 | 0.200 |
Why?
|
| Aged | 4 | 2024 | 14282 | 0.190 |
Why?
|
| Cross Reactions | 2 | 2021 | 131 | 0.190 |
Why?
|
| Adenovirus Infections, Human | 1 | 2021 | 3 | 0.190 |
Why?
|
| Adenoviruses, Human | 1 | 2021 | 9 | 0.190 |
Why?
|
| Coronavirus 229E, Human | 1 | 2021 | 2 | 0.180 |
Why?
|
| Air Microbiology | 1 | 2021 | 11 | 0.180 |
Why?
|
| Nasopharynx | 1 | 2020 | 22 | 0.180 |
Why?
|
| Environmental Microbiology | 1 | 2020 | 14 | 0.170 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 467 | 0.170 |
Why?
|
| Respiratory Tract Infections | 1 | 2021 | 89 | 0.170 |
Why?
|
| Genome, Viral | 1 | 2021 | 136 | 0.170 |
Why?
|
| Bird Diseases | 1 | 2020 | 2 | 0.170 |
Why?
|
| Antibody-Dependent Enhancement | 1 | 2020 | 4 | 0.170 |
Why?
|
| Swine Diseases | 1 | 2020 | 4 | 0.170 |
Why?
|
| Coronavirus | 1 | 2020 | 14 | 0.170 |
Why?
|
| Feces | 1 | 2020 | 112 | 0.170 |
Why?
|
| beta-Lactamases | 1 | 2020 | 13 | 0.170 |
Why?
|
| Military Personnel | 1 | 2021 | 117 | 0.160 |
Why?
|
| Gram-Negative Bacteria | 1 | 2020 | 57 | 0.160 |
Why?
|
| Massachusetts | 1 | 2024 | 2061 | 0.150 |
Why?
|
| Family Characteristics | 1 | 2018 | 44 | 0.150 |
Why?
|
| Asymptomatic Diseases | 1 | 2018 | 49 | 0.150 |
Why?
|
| Prospective Studies | 3 | 2020 | 3260 | 0.140 |
Why?
|
| Phylogeny | 1 | 2019 | 375 | 0.140 |
Why?
|
| Influenza A virus | 1 | 2018 | 123 | 0.140 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 206 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 220 | 0.130 |
Why?
|
| Genotype | 1 | 2019 | 664 | 0.130 |
Why?
|
| Antiviral Agents | 2 | 2021 | 322 | 0.130 |
Why?
|
| Infant | 2 | 2018 | 1629 | 0.130 |
Why?
|
| Body Fluids | 1 | 2016 | 21 | 0.130 |
Why?
|
| Animals | 6 | 2021 | 20640 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2018 | 207 | 0.120 |
Why?
|
| Cell Transformation, Viral | 1 | 2015 | 15 | 0.120 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2015 | 9 | 0.120 |
Why?
|
| Virus Integration | 1 | 2015 | 32 | 0.120 |
Why?
|
| Isoxazoles | 1 | 2015 | 12 | 0.120 |
Why?
|
| Membrane Proteins | 1 | 2021 | 894 | 0.120 |
Why?
|
| Ciprofloxacin | 1 | 2015 | 25 | 0.120 |
Why?
|
| Organophosphonates | 1 | 2015 | 22 | 0.120 |
Why?
|
| Cytosine | 1 | 2015 | 31 | 0.120 |
Why?
|
| Young Adult | 3 | 2023 | 4650 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2018 | 990 | 0.110 |
Why?
|
| Carcinoma | 1 | 2015 | 126 | 0.110 |
Why?
|
| Risk Factors | 3 | 2019 | 5312 | 0.110 |
Why?
|
| Blotting, Southern | 1 | 2013 | 55 | 0.110 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 145 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 787 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2013 | 113 | 0.110 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 5418 | 0.100 |
Why?
|
| Genome, Human | 1 | 2015 | 239 | 0.100 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 135 | 0.100 |
Why?
|
| DNA Primers | 1 | 2013 | 293 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2013 | 364 | 0.100 |
Why?
|
| Kidney Transplantation | 1 | 2015 | 315 | 0.100 |
Why?
|
| Base Sequence | 1 | 2013 | 1335 | 0.090 |
Why?
|
| Obesity | 1 | 2018 | 1231 | 0.080 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 1595 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 1997 | 0.080 |
Why?
|
| Antigens, Viral, Tumor | 2 | 2015 | 5 | 0.060 |
Why?
|
| Culture Techniques | 1 | 2022 | 12 | 0.050 |
Why?
|
| Informed Consent | 1 | 2023 | 139 | 0.050 |
Why?
|
| Environmental Pollution | 1 | 2022 | 14 | 0.050 |
Why?
|
| Cell Degranulation | 1 | 2022 | 20 | 0.050 |
Why?
|
| Aedes | 1 | 2021 | 12 | 0.050 |
Why?
|
| Mosquito Vectors | 1 | 2021 | 13 | 0.050 |
Why?
|
| Antibodies, Blocking | 1 | 2021 | 39 | 0.050 |
Why?
|
| Microbial Viability | 1 | 2021 | 58 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2021 | 115 | 0.040 |
Why?
|
| China | 1 | 2021 | 165 | 0.040 |
Why?
|
| Birds | 1 | 2020 | 9 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2022 | 670 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 173 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 207 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2020 | 131 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 393 | 0.040 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2020 | 57 | 0.040 |
Why?
|
| Time Factors | 2 | 2018 | 3752 | 0.040 |
Why?
|
| Swine | 1 | 2020 | 370 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2018 | 28 | 0.040 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2020 | 164 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 208 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 180 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2020 | 384 | 0.040 |
Why?
|
| Cell Line | 1 | 2021 | 2039 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 855 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2015 | 10 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2015 | 48 | 0.030 |
Why?
|
| Allografts | 1 | 2015 | 46 | 0.030 |
Why?
|
| Urothelium | 1 | 2015 | 22 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 976 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2015 | 250 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2015 | 56 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 668 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1541 | 0.030 |
Why?
|
| Capsid Proteins | 1 | 2015 | 98 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2018 | 1349 | 0.030 |
Why?
|
| Biopsy | 1 | 2015 | 431 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 521 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2023 | 6565 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2015 | 981 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2015 | 706 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2158 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1536 | 0.020 |
Why?
|
| United States | 1 | 2021 | 7758 | 0.020 |
Why?
|